Finepoint Capital LP reported 9 holdings worth US$2.8B as of Jun 30, 2026 (Form 13F)
As of Jun 30, 2026 · Filed Aug 13, 2026
Finepoint Capital LP reported 9 holdings worth US$2.8B as of Jun 30, 2026. Largest: Qxo, Inc., Rxo, Inc. and Aleanna, Inc. Filed Aug 13, 2026 (Form 13F).
- Holdings
- 9
- Value as reported
- US$2.8B
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|---|---|---|
| Qxo, Inc. | 18.1M | US$313M | 11.2% |
| Rxo, Inc. | 5.36M | US$148M | 5.3% |
| Aleanna, Inc. | 27,717 | US$80,379 | <0.01% |
| Calidi Biotherapeutics, Inc. | 1,042 | US$177 | <0.01% |